Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform.
Molecules. 2021 Mar 29;26(7):1912. doi: 10.3390/molecules26071912.
Molecules. 2021.
PMID: 33805419
Free PMC article.
Entering the era of computationally driven drug development.
Maharao N, Antontsev V, Wright M, Varshney J.
Maharao N, et al.
Drug Metab Rev. 2020 May;52(2):283-298. doi: 10.1080/03602532.2020.1726944. Epub 2020 Feb 21.
Drug Metab Rev. 2020.
PMID: 32083960
Review.
Item in Clipboard
Scalable in silico Simulation of Transdermal Drug Permeability: Application of BIOiSIM Platform.
Maharao N, Antontsev V, Hou H, Walsh J, Varshney J.
Maharao N, et al.
Drug Des Devel Ther. 2020 Jun 11;14:2307-2317. doi: 10.2147/DDDT.S253064. eCollection 2020.
Drug Des Devel Ther. 2020.
PMID: 32606600
Free PMC article.
Item in Clipboard
Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450.
Bansal S, Maharao N, Paine MF, Unadkat JD.
Bansal S, et al. Among authors: maharao n.
Drug Metab Dispos. 2020 Oct;48(10):1008-1017. doi: 10.1124/dmd.120.000073. Epub 2020 Jun 25.
Drug Metab Dispos. 2020.
PMID: 32587099
Free PMC article.
Item in Clipboard
A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics.
Cox EJ, Maharao N, Patilea-Vrana G, Unadkat JD, Rettie AE, McCune JS, Paine MF.
Cox EJ, et al. Among authors: maharao n.
Pharmacol Ther. 2019 Sep;201:25-38. doi: 10.1016/j.pharmthera.2019.05.001. Epub 2019 May 7.
Pharmacol Ther. 2019.
PMID: 31071346
Free PMC article.
Review.
Item in Clipboard
Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailability.
Maharao N, Venitz J, Gerk PM.
Maharao N, et al.
Biopharm Drug Dispos. 2019 Jan;40(1):18-31. doi: 10.1002/bdd.2166. Epub 2019 Jan 1.
Biopharm Drug Dispos. 2019.
PMID: 30520057
Item in Clipboard
Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of concept.
Maharao NV, Joshi AA, Gerk PM.
Maharao NV, et al.
Biopharm Drug Dispos. 2017 Mar;38(2):139-154. doi: 10.1002/bdd.2050. Epub 2017 Jan 24.
Biopharm Drug Dispos. 2017.
PMID: 27925249
Item in Clipboard
Cite
Cite